- Record: found
- Abstract: not found
- Article: not found
A double-blind randomized placebo controlled study assessing safety, tolerability and efficacy of palmitoylethanolamide for symptoms of knee osteoarthritis
There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.
Abstract
The aim of the study was to assess the safety, tolerability and efficacy of palmitoylethanolamide
(PEA) when dosed at 300 mg and 600 mg per day on symptoms of knee osteoarthritis.